Blueshift Asset Management’s Roivant Sciences ROIV Stock Holding History

Blueshift Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Buy	+30,383	New	+$898K	0.25%	60
2026 Q1	–	Sell	-31,767	Closed	-$689K	–	630
2025 Q4	$689K	Buy	+31,767	New	+$627K	0.2%	147
2024 Q3	–	Sell	-24,580	Closed	-$260K	–	458
2024 Q2	$260K	Buy	+24,580	New	+$269K	0.09%	275
2023 Q3	–	Sell	-19,302	Closed	-$195K	–	399
2023 Q2	$195K	Buy	+19,302	New	+$173K	0.07%	308

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Blueshift Asset Management's ROIV Position: Q2 2026 in Review

Blueshift Asset Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 30,383 shares worth $1.08M. The stake represents 0.25% of the portfolio and ranks #60 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in ROIV as recently as Q4 2025.

Blueshift Asset Management first reported a position in ROIV in Q2 2023 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Blueshift Asset Management held 30,383 shares of Roivant Sciences worth $1.08M as of Q2 2026.
Roivant Sciences was a new Blueshift Asset Management position in Q2 2026.
Roivant Sciences made up 0.25% of Blueshift Asset Management's portfolio in Q2 2026, its #60 holding.
Blueshift Asset Management first reported a position in Roivant Sciences in Q2 2023 and has held it in 4 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.